Professional business directory

Find the best businesses and services near you. Discover verified companies across all industries.

Category: pro-active

pro-active Sep 18

ROACTEMRA 162 MG INJ SRG 0,9 ML (Tocilizumab)

ROACTEMRA 162 MG INJ SRG 0,9 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatmen

View Details
pro-active Sep 18

ROACTEMRA 20 MG/ML INJ FL 10 ML (Tocilizumab)

ROACTEMRA 20 MG/ML INJ FL 10 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatmen

View Details
pro-active Sep 18

ROACTEMRA 20 MG/ML INJ FL 20 ML (Tocilizumab)

ROACTEMRA 20 MG/ML INJ FL 20 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatmen

View Details
pro-active Sep 18

ROACTEMRA 20 MG/ML INJ FL 4 ML (Tocilizumab)

ROACTEMRA 20 MG/ML INJ FL 4 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatment

View Details
pro-active Sep 18

NOVOSEVEN 60K UI INJ FL + FL (Facteur de coagulation VIIa recombinant EPTACOG ALFA [activé])

NOVOSEVEN 60K UI INJ FL + FL (Facteur de coagulation VIIa recombinant EPTACOG ALFA [activé]) - Malad

View Details
pro-active Sep 18

NOVOSEVEN 8 MG (400K UI) INJ FL + FL (Facteur de coagulation VIIa recombinant EPTACOG ALFA [activé])

NOVOSEVEN 8 MG (400K UI) INJ FL + FL (Facteur de coagulation VIIa recombinant EPTACOG ALFA [activé])

View Details
pro-active Sep 18

NOVOSEVEN 8 MG (400K UI) INJ FL + SRG (Facteur de coagulation VIIa recombinant EPTACOG ALFA [activé])

NOVOSEVEN 8 MG (400K UI) INJ FL + SRG (Facteur de coagulation VIIa recombinant EPTACOG ALFA [activé]

View Details
pro-active Sep 18

ORENCIA 125 MG INJ SRG 1 ML + P/A (Abatacept)

ORENCIA 125 MG INJ SRG 1 ML + P/A (Abatacept) - Maladie rare sans désignation orpheline In combin

View Details
pro-active Sep 18

ORENCIA 250 MG PERF FL + SRG (Abatacept)

ORENCIA 250 MG PERF FL + SRG (Abatacept) - Maladie rare sans désignation orpheline In combination

View Details
pro-active Sep 18

MABTHERA 100 MG PERF FL 10 ML (Rituximab)

MABTHERA 100 MG PERF FL 10 ML (Rituximab) - Maladie rare sans désignation orpheline * Non-Hodgkin

View Details
pro-active Sep 18

MABTHERA 500 MG PERF FL 50 ML (Rituximab)

MABTHERA 500 MG PERF FL 50 ML (Rituximab) - Maladie rare sans désignation orpheline * Non-Hodgkin

View Details
pro-active Sep 18

NOVOSEVEN 1 MG (50K UI) INJ FL + FL (Facteur de coagulation VIIa recombinant EPTACOG ALFA [activé])

NOVOSEVEN 1 MG (50K UI) INJ FL + FL (Facteur de coagulation VIIa recombinant EPTACOG ALFA [activé])

View Details